SEC Form 4 · accession 0001127602-19-010923
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph W LaPlume
Officer — EVP, Corp Strategy & Develop
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 8:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2019 | S | 200 | $138.18 | D | 14,879 | D | |
| Common Stock | Mar 8, 2019 | S | 30 | $138.19 | D | 14,849 | D | |
| Common Stock | Mar 8, 2019 | S | 3 | $138.195 | D | 14,846 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $138.20 | D | 14,546 | D | |
| Common Stock | Mar 8, 2019 | S | 30 | $138.205 | D | 14,516 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $138.22 | D | 14,216 | D | |
| Common Stock | Mar 8, 2019 | S | 300 | $138.23 | D | 13,916 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $138.24 | D | 13,816 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $138.26 | D | 13,716 | D | |
| Common Stock | Mar 8, 2019 | S | 200 | $138.28 | D | 13,516 | D | |
| Common Stock | Mar 8, 2019 | S | 3 | $138.30 | D | 13,513 | D | |
| Common Stock | Mar 8, 2019 | S | 100 | $138.37 | D | 13,413 | D |
Table II — derivative securities
No Table II lines on this filing.